184 related articles for article (PubMed ID: 34781807)
1. CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage.
Soleimani A; Navarro A; Liu D; Herman SEM; Chuang SS; Slavutsky I; Narbaitz M; Safah H; Schmieg J; Lefante J; Roschewski M; Wilson WH; Wiestner A; Saba NS
Leuk Lymphoma; 2022 Apr; 63(4):911-917. PubMed ID: 34781807
[TBL] [Abstract][Full Text] [Related]
2. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
[TBL] [Abstract][Full Text] [Related]
3. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
4. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
5. Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment.
Jain AG; Chang CC; Ahmad S; Mori S
Curr Treat Options Oncol; 2019 Nov; 20(12):85. PubMed ID: 31776787
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
[No Abstract] [Full Text] [Related]
7. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
[TBL] [Abstract][Full Text] [Related]
8. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
9. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
11. The pathologic diagnosis of mantle cell lymphoma.
Li S; Xu J; You MJ
Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
13. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
14. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
Ondrejka SL; Lai R; Smith SD; Hsi ED
Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
[TBL] [Abstract][Full Text] [Related]
15. How I manage mantle cell lymphoma: indolent versus aggressive disease.
Wilson MR; Barrett A; Cheah CY; Eyre TA
Br J Haematol; 2023 Apr; 201(2):185-198. PubMed ID: 36807902
[TBL] [Abstract][Full Text] [Related]
16. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients.
Matutes E; Parry-Jones N; Brito-Babapulle V; Wotherspoon A; Morilla R; Atkinson S; Elnenaei MO; Jain P; Giustolisi GM; A'Hern RP; Catovsky D
Leuk Lymphoma; 2004 Oct; 45(10):2007-15. PubMed ID: 15370245
[TBL] [Abstract][Full Text] [Related]
17. Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
Condoluci A; Rossi D; Zucca E; Cavalli F
Curr Oncol Rep; 2018 Aug; 20(10):79. PubMed ID: 30132080
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2017 Aug; 92(8):806-813. PubMed ID: 28699667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
